185 related articles for article (PubMed ID: 32562649)
1. Use of controlled temperature chain and compact prefilled auto-disable devices to reach 2030 hepatitis B birth dose vaccination targets in LMICs: a modelling and cost-optimisation study.
Seaman CP; Morgan C; Howell J; Xiao Y; Spearman CW; Sonderup M; Lesi O; Andersson MI; Hellard ME; Scott N
Lancet Glob Health; 2020 Jul; 8(7):e931-e941. PubMed ID: 32562649
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study.
Scott N; Palmer A; Morgan C; Lesi O; Spearman CW; Sonderup M; Hellard M
Lancet Glob Health; 2018 Jun; 6(6):e659-e667. PubMed ID: 29773122
[TBL] [Abstract][Full Text] [Related]
3. Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study.
Nayagam S; de Villiers MJ; Shimakawa Y; Lemoine M; Thursz MR; Walsh N; Hallett TB
Lancet Gastroenterol Hepatol; 2023 Jul; 8(7):635-645. PubMed ID: 37150181
[TBL] [Abstract][Full Text] [Related]
4. Countries' interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions.
Petit D; Tevi-Benissan C; Woodring J; Hennessey K; Kahn AL
Vaccine; 2017 Dec; 35(49 Pt B):6866-6871. PubMed ID: 29132994
[TBL] [Abstract][Full Text] [Related]
5. Requirements for global elimination of hepatitis B: a modelling study.
Nayagam S; Thursz M; Sicuri E; Conteh L; Wiktor S; Low-Beer D; Hallett TB
Lancet Infect Dis; 2016 Dec; 16(12):1399-1408. PubMed ID: 27638356
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the potential cost-effectiveness of microarray patches to expand access to hepatitis B birth dose vaccination in low-and middle-income countries: A modelling study.
Seaman CP; Mvundura M; Frivold C; Morgan C; Jarrahian C; Howell J; Hellard M; Scott N
PLOS Glob Public Health; 2022; 2(5):e0000394. PubMed ID: 36962423
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NéoVac Study).
Gosset A; Diallo MY; Betsem E; Schaeffer L; Meda N; Vray M; Sombie R; Shimakawa Y; Boyer S
Vaccine; 2021 Jul; 39(33):4659-4670. PubMed ID: 34238606
[TBL] [Abstract][Full Text] [Related]
8. Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models.
de Villiers MJ; Gamkrelidze I; Hallett TB; Nayagam S; Razavi H; Razavi-Shearer D
PLoS One; 2020; 15(8):e0237525. PubMed ID: 32776972
[TBL] [Abstract][Full Text] [Related]
9. Improving hepatitis B birth dose coverage through village health volunteer training and pregnant women education.
Li X; Heffelfinger J; Wiesen E; Diorditsa S; Valiakolleri J; Nikuata AB; Nukuro E; Tabwaia B; Woodring J
Vaccine; 2017 Aug; 35(34):4396-4401. PubMed ID: 28688784
[TBL] [Abstract][Full Text] [Related]
10. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the immunogenicity and safety of pentavalent vaccine Quinvaxem in a compact prefilled auto-disabled (cPAD) injection system versus single-dose vials in healthy infants: a phase 3, open-label, randomized, parallel-group, non-inferiority study.
Capeding MR; Alberto E; Versteilen A; Rauscher M; Bagchi P; Palacios PI
Int J Infect Dis; 2016 May; 46():71-8. PubMed ID: 26923083
[TBL] [Abstract][Full Text] [Related]
12. Barriers to the delivery of the hepatitis B birth dose: a study of five Papua New Guinean hospitals in 2007.
Downing SG; Lagani W; Guy R; Hellard M
P N G Med J; 2008; 51(1-2):47-55. PubMed ID: 19999309
[TBL] [Abstract][Full Text] [Related]
13. Preventing hepatitis B and hepatocellular carcinoma in South Africa: The case for a birth-dose vaccine.
Spearman CW; Sonderup MW
S Afr Med J; 2014 Jul; 104(9):610-2. PubMed ID: 25212400
[TBL] [Abstract][Full Text] [Related]
14. Implementation of newborn hepatitis B vaccination--worldwide, 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1249-52. PubMed ID: 19023261
[TBL] [Abstract][Full Text] [Related]
15. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342
[No Abstract] [Full Text] [Related]
16. Impact of the national hepatitis B immunization program in China: a modeling study.
Liu Z; Li M; Hutton DW; Wagner AL; Yao Y; Zhu W; Cao L; Tang S; Pan J; Wang Y; Zhao Q; Ren H; Wang Y; Wang W
Infect Dis Poverty; 2022 Oct; 11(1):106. PubMed ID: 36221140
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation.
Cui F; Luo H; Wang F; Zheng H; Gong X; Chen Y; Wu Z; Miao N; Kane M; Hennessey K; Hadler SC; Hutin YJ; Liang X; Yang W
Vaccine; 2013 Dec; 31 Suppl 9():J36-42. PubMed ID: 24331019
[TBL] [Abstract][Full Text] [Related]
18. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
[TBL] [Abstract][Full Text] [Related]
19. Compliance with birth dose of Hepatitis B vaccine in high endemic and hard to reach areas in the Colombian amazon: results from a vaccination survey.
Choconta-Piraquive LA; De la Hoz-Restrepo F; Sarmiento-Limas CA
BMC Health Serv Res; 2016 Jul; 16():293. PubMed ID: 27443313
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
